228 related articles for article (PubMed ID: 28165585)
21. Evolving therapies for hepatitis C virus in chronic kidney disease: the beginning of a new era.
Gordon CE; Nader C
Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):129-135. PubMed ID: 27906748
[TBL] [Abstract][Full Text] [Related]
22. Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management.
Jadoul M; Berenguer MC; Doss W; Fabrizi F; Izopet J; Jha V; Kamar N; Kasiske BL; Lai CL; Morales JM; Patel PR; Pol S; Silva MO; Balk EM; Gordon CE; Earley A; Di M; Martin P
Kidney Int; 2018 Oct; 94(4):663-673. PubMed ID: 30243313
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C Virus Infection in Kidney Transplant Patients: Current Treatment Options.
Dzekova-Vidimliski P; Sikole A
Exp Clin Transplant; 2017 Dec; 15(6):587-593. PubMed ID: 29219790
[TBL] [Abstract][Full Text] [Related]
24. Management of hepatitis C infection among patients with renal failure.
Latt NL; Araz F; Alachkar N; Durand CM; Gurakar A
Minerva Gastroenterol Dietol; 2015 Mar; 61(1):39-49. PubMed ID: 25390288
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C treatment in patients with kidney disease.
Fabrizi F; Aghemo A; Messa P
Kidney Int; 2013 Nov; 84(5):874-9. PubMed ID: 23823603
[TBL] [Abstract][Full Text] [Related]
26. Curative Therapies for Hepatitis C Virus Infection in Patients with Kidney Disease.
Strohbehn IA; Seethapathy R; Lee M; Sise ME
Kidney360; 2021 Aug; 2(8):1316-1325. PubMed ID: 35369667
[TBL] [Abstract][Full Text] [Related]
27. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL;
Dig Liver Dis; 2018 Nov; 50(11):1133-1152. PubMed ID: 30266305
[TBL] [Abstract][Full Text] [Related]
28. New and Emerging Evidence on the Use of Second-Generation Direct Acting Antivirals for the Treatment of Hepatitis C Virus in Renal Impairment.
Sorbera MA; Friedman ML; Cope R
J Pharm Pract; 2017 Jun; 30(3):359-365. PubMed ID: 26902648
[TBL] [Abstract][Full Text] [Related]
29. 'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.
García-Agudo R; Aoufi-Rabih S; Salgueira-Lazo M; González-Corvillo C; Fabrizi F
Int J Artif Organs; 2018 Jul; 41(7):363-370. PubMed ID: 29582685
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approach.
Constancio NS; Ferraz MLG; Martins CTB; Kraychete AC; Bitencourt PL; Nascimento MMD
J Bras Nefrol; 2019; 41(4):539-549. PubMed ID: 30806444
[TBL] [Abstract][Full Text] [Related]
31. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
[TBL] [Abstract][Full Text] [Related]
32. Virological tools to diagnose and monitor hepatitis C virus infection.
Chevaliez S
Clin Microbiol Infect; 2011 Feb; 17(2):116-21. PubMed ID: 21054664
[TBL] [Abstract][Full Text] [Related]
33. Therapy of hepatitis C by direct-acting anti-virals: the end of HCV in dialysis population?
Fabrizi F; Messa P
Expert Rev Clin Pharmacol; 2015; 8(6):785-93. PubMed ID: 26365524
[TBL] [Abstract][Full Text] [Related]
34. When and how can nephrologists treat hepatitis C virus infection in dialysis patients?
Davis MI; Chute DF; Chung RT; Sise ME
Semin Dial; 2018 Jan; 31(1):26-36. PubMed ID: 28925068
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis.
Vukotic R; Conti F; Fagiuoli S; Morelli MC; Pasulo L; Colpani M; Foschi FG; Berardi S; Pianta P; Mangano M; Donato MF; Malinverno F; Monico S; Tamè M; Mazzella G; Belli LS; Viganò R; Carrai P; Burra P; Russo FP; Lenci I; Toniutto P; Merli M; Loiacono L; Iemmolo R; Degli Antoni AM; Romano A; Picciotto A; Rendina M; Andreone P;
J Viral Hepat; 2017 Oct; 24(10):858-864. PubMed ID: 28370880
[TBL] [Abstract][Full Text] [Related]
36. [Viral hepatitis C in patients with terminal chronic renal insufficiency. III. Viral quantification].
González-Michaca L; Soto-Ramírez LE; Rodríguez R; Gamba G
Rev Invest Clin; 2001; 53(1):21-7. PubMed ID: 11332047
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C in Chronic Kidney Disease: An Overview of the KDIGO Guideline.
Awan AA; Jadoul M; Martin P
Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2158-2167. PubMed ID: 31376491
[TBL] [Abstract][Full Text] [Related]
38. Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic.
Bajis S; Applegate TL; Grebely J; Matthews GV; Dore GJ
J Infect Dis; 2020 Nov; 222(Suppl 9):S758-S772. PubMed ID: 33245354
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and Treatment of Untypable HCV Variants in Different Districts of Punjab, Pakistan.
Zafar A; Imran M; Zahoor S; Shah ZH; Ali M; Afzal MS
Viral Immunol; 2018; 31(6):426-432. PubMed ID: 29920175
[TBL] [Abstract][Full Text] [Related]
40. Pharmacology Update for the Treatment of Hepatitis C Virus.
Hopkins L; Dunlap T; Cline H
Nurs Clin North Am; 2020 Sep; 55(3):347-359. PubMed ID: 32762855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
